[Leishmaniasis: hospital and population-based incidence, and asymptomatic infection. A disease that is still with us].
Bellido-Blasco
Juan B
JB
Arnedo-Pena
Alberto
A
Romeo-García
Maria Angeles
MA
Herrero-Carot
Concha
C
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D015897:Comorbidity; D004197:Disease Reservoirs; D004283:Dog Diseases / Q000188:drug therapy / Q000453:epidemiology; D004285:Dogs; D004363:Drug Utilization / Q000706:statistics & numerical data; D015658:HIV Infections / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007896:Leishmaniasis / Q000188:drug therapy / Q000453:epidemiology* / Q000662:veterinary; D007898:Leishmaniasis, Visceral / Q000188:drug therapy / Q000453:epidemiology; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D013030:Spain
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate